(2008. szeptember 1.) „Paradoxical aggressive reactions to benzodiazepine use: a review” (francia nyelven). L'Encéphale34 (4), 330–6. o. DOI:10.1016/j.encep.2007.05.005. PMID 18922233.
(2017. március 1.) „Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature”. The Primary Care Companion for CNS Disorders19 (2). DOI:10.4088/PCC.16r02037. PMID 28257172.
(2007. szeptember 1.) „Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials”. Journal of Psychopharmacology21 (7), 774–82. o. DOI:10.1177/0269881107077355. PMID 17881433.
de Gage, S. B., Bégaud, B., Bazin, F., Verdoux, H., Dartigues, J. F., Pérès, K., & Pariente, A. (2012). „Benzodiazepine use and risk of dementia: prospective population based study” (angol nyelven). BMJ345. DOI:10.1136/bmj.e6231.
(1995) „Use and abuse of benzodiazepines in Hong Kong 1990-1993--the impact of regulatory changes”. Journal of Toxicology: Clinical Toxicology33 (6), 597–602. o. DOI:10.3109/15563659509010615. PMID 8523479.
(2009) „A systematic review of research examining benzodiazepine-related mortality”. Pharmacoepidemiology and Drug Safety18 (2), 93–103. o. DOI:10.1002/pds.1694. PMID 19125401.
(2008. szeptember 1.) „Paradoxical aggressive reactions to benzodiazepine use: a review” (francia nyelven). L'Encéphale34 (4), 330–6. o. DOI:10.1016/j.encep.2007.05.005. PMID 18922233.
(2017. március 1.) „Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature”. The Primary Care Companion for CNS Disorders19 (2). DOI:10.4088/PCC.16r02037. PMID 28257172.
(2005) „Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents”. The Journal of Clinical Psychiatry66 (Suppl 2), 21–7. o. PMID 15762816. „The frequent use of benzodiazepines for the treatment of anxiety is likely a reflection of their effectiveness, rapid onset of anxiolytic effect, and tolerability.”
(2007. szeptember 1.) „Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials”. Journal of Psychopharmacology21 (7), 774–82. o. DOI:10.1177/0269881107077355. PMID 17881433.
Chouinard G (2004). „Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound”. The Journal of clinical psychiatry65 (Suppl 5), 7–12. o. PMID 15078112.
(1995) „Use and abuse of benzodiazepines in Hong Kong 1990-1993--the impact of regulatory changes”. Journal of Toxicology: Clinical Toxicology33 (6), 597–602. o. DOI:10.3109/15563659509010615. PMID 8523479.
(2009) „A systematic review of research examining benzodiazepine-related mortality”. Pharmacoepidemiology and Drug Safety18 (2), 93–103. o. DOI:10.1002/pds.1694. PMID 19125401.